Mephentermine is a sympathomimetic amine that acts directly as well as indirectly via an action on αand β-adrenergic receptors. It increases blood pressure by augmenting cardiac output and also by peripheral venoconstriction. Mephentermine is commonly used in India for the management of spinal anaesthesia-induced hypotension. However ephedrine, another sympathomimetic drug acting on both αand β-adrenergic receptors, is widely used in many parts of the world 1 . A comparison of ephedrine and mephentermine for the treatment of spinal anaesthesia-induced hypotension during caesarean section found that mephentermine was as safe and effective as ephedrine for maintenance of maternal blood pressure and for foetal outcome 2 .
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In a previous study we compared mephentermine and ephedrine for prophylaxis of hypotension following spinal anaesthesia during caesarean section 3 . The study was designed to determine the minimum effective doses (ED 50 ) of the two vasopressors and thus to estimate a potency ratio, using Dixon's up-down method of sequential allocation of doses. A starting dose of 50 mg and a dose interval of 5 mg were chosen for both vasopressor drugs. Contrary to the assumption that ephedrine and mephentermine are equipotent, mephentermine proved more potent than ephedrine for prophylaxis of hypotension. The ED 50 of ephedrine was 25.0 mg (95% confidence interval [CI] 15.5 to 40.4 mg) but the ED 50 of mephentermine could not be calculated due to success of the minimum dose allowed by the study design. However, it appeared to be much less than that of ephedrine. Thus the present study was designed, using a lower starting dose and smaller dose interval of mephentermine, to determine the ED 50 of mephentermine and allow calculation of a potency ratio with ephedrine in this setting.
MATERIALS AND METHODS
After approval from the institutional ethics committee, a prospective sequential allocation study was conducted. Written informed consent was obtained from all patients and the inclusion and exclusion criteria, patient preparation, anaesthetic technique and monitoring were identical to that used in the earlier study 3 .
The previous study indicated that the minimum effective dose of mephentermine was less than 5 mg, so a starting dose of 5 mg and dose interval of 1 mg were used. The first patient received 5 mg of mephentermine diluted to 20 ml with normal saline and the infusion was started at 40 ml/h using an 
SuMMARy
This study was designed to determine the minimum effective dose (ED 50 ) of mephentermine for prevention of post-spinal hypotension in women undergoing elective caesarean section. Dixon's up-down method of sequential allocation was used to determine the patient's dose of vasopressor drug. In our previous study, mephentermine appeared to be much more potent than ephedrine, so the present study was conducted using a lower initial dose and smaller dose interval for this vasopressor. Following administration of spinal anaesthesia, a prophylactic infusion of mephentermine was started with 5 mg infused over a period of 30 minutes as the initial dose and a dose interval of 1 mg. The ED 50 of mephentermine of 3.7 mg (95% confidence interval 2.4 to 5.7 mg) was much less than that of ephedrine, as calculated in our previous study using the same methodology. Using these values gives a potency ratio of ephedrine to mephentermine of 1:6.8 (95% confidence interval 6.0 to 7.5). Emco Infusor 850 syringe infusion pump (Emco Meditek Pvt Ltd, Mumbai, India). If hypotension occurred during the study period, that particular dose was considered ineffective and the next successive patient received a dose increased by 1 mg. If, on the other hand, hypotension was prevented, this dose was considered effective and the dose for the next patient was decreased by 1 mg. The calculations of baseline and hypotensive values of systolic blood pressure and the management of hypotension and systolic blood pressure exceeding the baseline value remained the same as the previous study 3 .
Potency of mePhentermine

Statistical analysis
Statistical analysis was performed using Statistical package for SPSS version 13.0. The up-down method of Dixon 4 was used to calculate the ED 50 with 95% CI of mephentermine and using this method, 22 patients were included in the study.
RESuLTS
Table 1 shows demographic and other characteristics of the patients included in the study.
The sequence of dose against patient for mephentermine is shown in Figure 1 . The ED 50 of mephentermine was 3.7 mg (95% CI 2.4 to 5.7 mg), calculated using the formula of Dixon and Massey 5 .
Heart rate increased to more than 130 beats/min in three patients. It dropped below 60 beats/min in two patients, however neither of these patients received atropine. The rate of the mephentermine infusion was reduced to 32 ml/min in one patient because the peak systolic blood pressure rose 9 mmHg above the baseline value. One patient developed shivering, however no other complication (e.g. nausea, vomiting, chest pain or arrhythmia) was observed in any of the patients.
DISCuSSION
The ED 50 of mephentermine, as calculated in the present study, represents the dose infused over a period of 30 minutes that would prevent hypotension in 50% of patients undergoing caesarean section under spinal anaesthesia following 10 ml/kg intravenous crystalloid preload. In the previous study we calculated an ED 50 for ephedrine of 25.0 mg (95% CI 15.5 to 40.4 mg) 3 . On this basis, the potency ratio of ephedrine to mephentermine is 1:6.8 (95% CI 6.0 to 7.5). Thus mephentermine is 6.8 times more potent than ephedrine in preventing post-spinal hypotension in patients undergoing caesarean section.
In clinical trials, similar doses of ephedrine and mephentermine have been used and found to be effective for treatment of post-spinal hypotension at caesarean section 2,6 . However, neither of these studies was a dose-response study and predetermined doses were used. Our dose-response studies confirmed that, in this clinical situation, mephentermine is more potent than ephedrine and that there is a lower dose requirement. Besides difference in potency, the longer half-life of mephentermine compared with ephedrine may also contribute to its lower infusion dose requirements for prevention of hypotension 7, 8 . This study design could not be double-blind. However, the observations were objective and unlikely to introduce bias. Because there was only one group for all eligible patients, the chance of introducing bias by modification of study design was negligible.
Mephentermine is available in a 10 ml vial containing 30 mg/ml of mephentermine sulphate, the cost of which is 144 rupees, so 30 mg costs approximately 14.50 rupees. Ephedrine is available as a 1 ml ampoule containing 30 mg ephedrine hydrochloride and costs approximately 15 rupees, making the cost of these two drugs per 30 mg very similar. However, because of the higher potency and lower dose requirement of mephentermine, its cost per individual patient should be much less.
In our studies, no significant adverse effects of mephentermine were detected when it was used either for prevention or treatment of post-spinal hypotension in patients undergoing caesarean section 2,3 . Foetal effects as assessed by cord blood gases and Apgar scores were comparable with mephentermine and ephedrine 2 . We consider that the lower cost per patient but similar performance to ephedrine makes mephentermine a good choice of vasopressor drug for the management of hypotension in countries in which it is freely available.
In conclusion, we have calculated for the first time an ED 50 for mephentermine and compared its potency with ephedrine when used for prophylaxis of post-spinal hypotension. The ED 50 of the mephentermine infusion for 30 minutes was 3.7 mg (95% CI 2.4 to 5.7 mg) and it was 6.8 times more potent than ephedrine.
